Reducing oxidative stress may be important for treating pirarubicin-induced cardiotoxicity with schisandrin B.

Tang, Heng; Zhao, Junhao; Feng, Rui; Pu, Peng; Wen, Li

Tang, Heng; Zhao, Junhao; Feng, Rui; Pu, Peng; Wen, Li.

Afiliação

Tang H; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China.
Zhao J; The First Clinical College, Jinyun Mountain Campus of Chongqing Medical University, Chongqing 401331, P.R. China.
Feng R; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China.
Pu P; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China.
Wen L; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China.

Exp Ther Med ; 23(1): 68, 2022 Jan.

Article em En | MEDLINE | ID: mdl-34934439

Palavras-chave

cardiotoxicity; oxidative stress; pirarubicin; schisandrin B

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Ther Med Ano de publicação: 2022 Tipo de documento: Article País de publicação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google